Journal - Current Molecular Medicine

Impact Factor

Current: 2.222
5 - Year: 3.084

Ranking & Category

82nd of 133 in Medicine, research & Experimental

Topic(s) Covered

1 Topic(s)

View

Covered Disease(s)

0 Disease(s)

Aims & Scope

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Abstracted/Indexed in

BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Biotechnology Citation Index®, British Library, Cabell's Directory, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Current Contents® - Clinical Medicine, Current Contents® - Life Sciences, Dimensions, EBSCO, EMBASE/Excerpta Medica, EMBiology, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus Index to Scientific Reviews®, ISI Alerting Service, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

Journal History

Current Molecular Medicine was introduced in 2001. Dr. Andras Guttman serves as the Editor-in-Chief of the journal.

COPE COMPLIANT

Endorsement(s)

"A critically important journal that fills an important niche."

David Weiner
Pennsylvania School of Medicine, USA

Authors' Comments

My experience working with Bentham Science Publishers was excellent and among the best I've had with publishing anywhere. I worked with Ms. Samina Khan at Bentham. She was prompt to respond and her responses were always helpful. We have had a number of correspondences and she always worked things through to completion.

John Paul SanGiovanni
(National Eye Institute, Bethesda, USA)

Has contributed: Application and Interpretation of Genome-Wide Association (GWA) Studies for Informing Pharmacogenomic Research – Examples from the Field of Age-Related Macular Degeneration